RP Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,111,111
| Closed | -$168M | – | 4 |
|
|
2022
Q3 | $168M | Hold |
1,111,111
| – | – | 77.6% | 1 |
|
|
2022
Q2 | $162M | Hold |
1,111,111
| – | – | 63.94% | 1 |
|
|
2022
Q1 | $132M | Hold |
1,111,111
| – | – | 53.58% | 1 |
|
|
2021
Q4 | $153M | Hold |
1,111,111
| – | – | 64.09% | 1 |
|
|
2021
Q3 | $154M | Hold |
1,111,111
| – | – | 72.03% | 1 |
|
|
2021
Q2 | $108M | Sell |
1,111,111
-1,000,000
| -47% | -$97.1M | 52.6% | 1 |
|
|
2021
Q1 | $144M | Hold |
2,111,111
| – | – | 54.16% | 1 |
|
|
2020
Q4 | $181M | Hold |
2,111,111
| – | – | 55.51% | 1 |
|
|
2020
Q3 | $137M | Hold |
2,111,111
| – | – | 20.57% | 2 |
|
|
2020
Q2 | $154M | Hold |
2,111,111
| – | – | 29.83% | 2 |
|
|
2020
Q1 | $71.8M | Hold |
2,111,111
| – | – | 22.3% | 2 |
|
|
2019
Q4 | $115M | Hold |
2,111,111
| – | – | 25.98% | 2 |
|
|
2019
Q3 | $88.1M | Hold |
2,111,111
| – | – | 56.41% | 1 |
|
|
2019
Q2 | $92.4M | Hold |
2,111,111
| – | – | 56.7% | 1 |
|
|
2019
Q1 | $109M | Hold |
2,111,111
| – | – | 54.35% | 1 |
|
|
2018
Q4 | $78.1M | Buy |
+2,111,111
| New | +$78.1M | 53.45% | 1 |
|